Ad
Friday, 21 July 2017
U.S. jury sides with Amphastar over Momenta in drug patent trial
BOSTON (Reuters) - A federal jury handed Amphastar Pharmaceuticals Inc a big win on Friday after it was accused of infringing on a patent held by Momenta Pharmaceuticals Inc through its production of a generic version of the blood-thinner Lovenox.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment